Vivesto maintains a robust patent protection strategy for XR-17™-formulated drugs, independent of the API used.
In addition to technical patents, Vivesto employs an aggressive IP strategy for its immaterial rights across jurisdictions around the world.
| Family name | Scope summary |
|---|---|
| Water-insoluble | Water-insoluble active substance formulated with XR-17 |
| XR-17 process | Improved process for the preparation of XR-17 component XMeNa |
| XR-17 process 2 | A further improved process for the preparation of XR-17 component XMeNa |
| XR-18 | XR-18 compounds and their use in drug formulation |
This summary provides an overview of the Drug Delivery Portfolio. Detailed information on granted patents and published applications is available from official patent authorities.